Kansal says that taking a low dose of a GLP-1 drug without the intent to stay on it long-term can be problematic
"This can manifest in various ways, with an unpleasant, abnormal or altered taste sensation, and is often described as metallic." A spokesperson for Eli Lilly, maker of Trulicity, Mounjaro and Zepbound, told USA TODAY in an email: "Patient safety is Lillys top priority, and we take any reports regarding patient safety seriously
Complete the Intake Share your goals, health history, and preferences
Embrace Your Authentic Beauty Each weekly treatment with either Tirzepatide or Semaglutide injections is quick and minimally invasive and can be self-administered at home or at our office
Ro does not offer any compounded GLP-1
Novo Nordisk's Amycretin - Evergreening The Franchise Part II At their 2024 capital markets day Novo Nordisk announced results for their second follow up to semaglutide Amycretin